Ed Kaplan, the national health practice leader at Segal, also has concerns about "any willing provider" strategies.

Another pressing concern for participants was the rise in drug costs, with 54% expecting at least half of U.S. states to establish drug-affordability boards. Additionally, 97% foresee a 25% surge in ...

Nicole Stallings, President and CEO of the Hospital and Healthsystem Association of Pennsylvania, discusses how hospitals aim to protect Medicaid from cuts.

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

For the percentage of people living in pharmacy deserts in the five states that the researchers identified as having the ...

Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...

The days of enduring endless elevator music while on hold and making long drives to your VA medical center to refill ...

Companies such as Rescription, MakoRx and Liviniti sell benefit plans giving employers steep discounts for costly ...

A bipartisan, end-of-the-year healthcare package including telehealth extensions, PBM reform and a physician fee schedule fix ...

The 340B federal drug pricing program has transformed into a system benefiting large hospital systems and corporate middlemen ...

Total health care expenditures per capita grew to $11,153 from 2022 to 2023, an 8.6% leap that was the second-largest ...

The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by ...